As Health Canada looks to improve the regulatory environment for new medicines in this country, both Pharmascience and AstraZeneca Canada are two of the top organizations from the pharmaceutical sector that lobbied the most this year to discuss that work with federal officia…
To keep reading, subscribe and become a political insider.SUBSCRIBE NOW Only $7.76 a week for an annual subscription.
Enjoy unlimited website access and the digital newspaper.
Cancel anytime.